首页 › 基金 › Sculptor Capital LP › GMED
Sculptor Capital LP 对 GMED 的持仓历史
GLOBUS MED INC · 医疗保健
Sculptor Capital LP 在 Q3 2026 的 13F 申报中披露持有 GMED(GLOBUS MED INC)814,700 股,市值约 US$61.0M,约占其申报组合的 0.83%,在其申报持仓中市值排名第 37 位。 Sculptor Capital LP 最近 12 个申报季度中有 12 个季度披露了 GMED 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Sculptor Capital LP 对 GMED 的持仓演变
Sculptor Capital LP 于 Q4 2023 首次披露 GMED 持仓:726,738 股(约 US$38.7M)。 该持仓在 Q1 2026 达到峰值 3,058,000 股,市值约 US$263.5M。 在 12 次申报中,Sculptor Capital LP 5 次增持、4 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 814,700 股、市值约 US$61.0M,环比减持 -2,185,300 股。。 持仓曾出现大幅变动:Q1 2024 增持约 204% (随后一个季度股价上涨 28%)、Q2 2025 增持约 32% (随后一个季度股价下跌 3%)、Q3 2026 减持约 73% (随后一个季度股价下跌 4%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 726.74K | $38.73M | 新进 |
| Q1 2024 | 2.21M | $118.58M | 增持 |
| Q2 2024 | 2.21M | $151.41M | 持有 |
| Q3 2024 | 2.21M | $158.16M | 持有 |
| Q4 2024 | 2.08M | $171.86M | 减持 |
| Q1 2025 | 2.09M | $153.20M | 增持 |
| Q2 2025 | 2.76M | $162.94M | 增持 |
| Q3 2025 | 3.50M | $200.44M | 增持 |
| Q4 2025 | 3.00M | $261.93M | 减持 |
| Q1 2026 | 3.06M | $263.48M | 增持 |
| Q2 2026 | 3.00M | $237.03M | 减持 |
| Q3 2026 | 814.70K | $61.02M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GMED 与 13F 数据
GMED(GLOBUS MED INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 GMED,申报仓位最大的包括:KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GMED 的基金
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 3.20M 股 · $239.44M · Q3 2026
- Boston Trust Walden Corp 1.64M 股 · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M 股 · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M 股 · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K 股 · $73.89M · Q2 2026
更多关于 Sculptor Capital LP
常见问题
How long has Sculptor Capital LP held GMED?
Sculptor Capital LP has disclosed GMED holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Sculptor Capital LP's current position in GMED?
As of Q3 2026, Sculptor Capital LP holds 814.70K shares of GMED (GLOBUS MED INC), valued at $61.02M, representing 0.83% of its reported portfolio and ranking #37.
Has Sculptor Capital LP been buying or selling GMED?
In the latest 13F filing (Q3 2026), Sculptor Capital LP reduced its position in GMED. The position peaked in Q1 2026 at 3.06M shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.